Login to Your Account



Other News To Note


Friday, February 8, 2013
• Alexion Pharmaceuticals Inc., of Cheshire, Conn., advised its stockholders to reject an unsolicited "mini-tender" offer by TRC Capital Corp. to purchase up to 1.5 million shares, or about 0.77 percent, of outstanding Alexion common stock at $90.50 per share.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription